Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cingulate Inc. stock logo
CING
Cingulate
$5.16
-1.3%
$6.44
$3.20
$11.89
$63.27M-0.81459,947 shs108,069 shs
Estrella Immunopharma, Inc. stock logo
ESLA
Estrella Immunopharma
$1.26
-0.8%
$1.35
$0.78
$3.15
$53.76M0.97163,718 shs10,713 shs
Lifevantage Corporation stock logo
LFVN
Lifevantage
$4.79
-4.5%
$4.71
$3.90
$15.00
$60.58M0.52201,475 shs93,689 shs
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
$2.75
+0.2%
$2.71
$2.33
$4.96
$16.96M0.422,334 shs2,031 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cingulate Inc. stock logo
CING
Cingulate
-1.88%+1.55%-11.95%-32.08%+33.42%
Estrella Immunopharma, Inc. stock logo
ESLA
Estrella Immunopharma
-2.31%-22.56%-26.16%-12.41%+13.39%
Lifevantage Corporation stock logo
LFVN
Lifevantage
-16.33%-0.59%+24.26%-0.20%-55.10%
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
+0.74%+2.62%+2.24%-14.64%-4.20%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cingulate Inc. stock logo
CING
Cingulate
$5.16
-1.3%
$6.44
$3.20
$11.89
$63.27M-0.81459,947 shs108,069 shs
Estrella Immunopharma, Inc. stock logo
ESLA
Estrella Immunopharma
$1.26
-0.8%
$1.35
$0.78
$3.15
$53.76M0.97163,718 shs10,713 shs
Lifevantage Corporation stock logo
LFVN
Lifevantage
$4.79
-4.5%
$4.71
$3.90
$15.00
$60.58M0.52201,475 shs93,689 shs
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
$2.75
+0.2%
$2.71
$2.33
$4.96
$16.96M0.422,334 shs2,031 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cingulate Inc. stock logo
CING
Cingulate
-1.88%+1.55%-11.95%-32.08%+33.42%
Estrella Immunopharma, Inc. stock logo
ESLA
Estrella Immunopharma
-2.31%-22.56%-26.16%-12.41%+13.39%
Lifevantage Corporation stock logo
LFVN
Lifevantage
-16.33%-0.59%+24.26%-0.20%-55.10%
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
+0.74%+2.62%+2.24%-14.64%-4.20%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cingulate Inc. stock logo
CING
Cingulate
2.33
Hold$34.50568.09% Upside
Estrella Immunopharma, Inc. stock logo
ESLA
Estrella Immunopharma
2.00
Hold$8.00534.92% Upside
Lifevantage Corporation stock logo
LFVN
Lifevantage
2.00
Hold$5.004.30% Upside
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest NAII, LFVN, ESLA, and CING Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/7/2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
DowngradeBuyHold$5.00
5/4/2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
DowngradeHold (C)Hold (C-)
4/29/2026
Estrella Immunopharma, Inc. stock logo
ESLA
Estrella Immunopharma
DowngradeSell (D-)Sell (E+)
4/20/2026
Cingulate Inc. stock logo
CING
Cingulate
Reiterated RatingSell (E+)
4/8/2026
Cingulate Inc. stock logo
CING
Cingulate
Lower Price TargetBuy$58.00 ➝ $55.00
3/27/2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
Reiterated RatingHold (C)
3/23/2026
Cingulate Inc. stock logo
CING
Cingulate
Lower Price TargetBuy$16.00 ➝ $14.00
2/9/2026
Estrella Immunopharma, Inc. stock logo
ESLA
Estrella Immunopharma
Reiterated RatingBuy$8.00
(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cingulate Inc. stock logo
CING
Cingulate
N/AN/AN/AN/A$0.31 per shareN/A
Estrella Immunopharma, Inc. stock logo
ESLA
Estrella Immunopharma
N/AN/AN/AN/A($0.27) per shareN/A
Lifevantage Corporation stock logo
LFVN
Lifevantage
$195.32M0.31$0.88 per share5.46$2.75 per share1.74
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
$129.86M0.13N/AN/A$11.07 per share0.25
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cingulate Inc. stock logo
CING
Cingulate
-$22.45M-$4.32N/AN/AN/AN/A-509.72%-172.37%5/14/2026 (Estimated)
Estrella Immunopharma, Inc. stock logo
ESLA
Estrella Immunopharma
-$13.06M-$0.35N/AN/AN/AN/AN/A-430.91%5/13/2026 (Estimated)
Lifevantage Corporation stock logo
LFVN
Lifevantage
$9.81M$0.4510.516.85N/A2.94%23.84%12.34%N/A
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
-$13.57M-$2.04N/AN/AN/A-9.06%-8.60%-3.92%5/12/2026 (Estimated)

Latest NAII, LFVN, ESLA, and CING Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2026Q1 2026
Cingulate Inc. stock logo
CING
Cingulate
-$0.53N/AN/AN/AN/AN/A
5/13/2026N/A
Estrella Immunopharma, Inc. stock logo
ESLA
Estrella Immunopharma
-$0.0840N/AN/AN/AN/AN/A
5/6/2026Q3 2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
$0.16$0.12-$0.04$0.11$47.77 million$43.72 million
3/18/2026Q4 2025
Cingulate Inc. stock logo
CING
Cingulate
-$0.56-$0.84-$0.28-$0.84N/AN/A
3/18/2026Q4 2025
Estrella Immunopharma, Inc. stock logo
ESLA
Estrella Immunopharma
-$0.18-$0.01+$0.17-$0.01N/AN/A
2/13/2026Q2 2026
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
N/A-$0.42N/A-$0.42N/A$34.80 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cingulate Inc. stock logo
CING
Cingulate
N/AN/AN/AN/AN/A
Estrella Immunopharma, Inc. stock logo
ESLA
Estrella Immunopharma
N/AN/AN/AN/AN/A
Lifevantage Corporation stock logo
LFVN
Lifevantage
$0.183.75%N/A40.00%3 Years
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
N/AN/AN/AN/AN/A

Latest NAII, LFVN, ESLA, and CING Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/27/2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
quarterly$0.054%6/1/20266/1/20266/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cingulate Inc. stock logo
CING
Cingulate
0.46
1.16
1.16
Estrella Immunopharma, Inc. stock logo
ESLA
Estrella Immunopharma
N/A
0.12
0.12
Lifevantage Corporation stock logo
LFVN
Lifevantage
N/A
2.03
1.03
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
0.13
1.87
0.85

Institutional Ownership

CompanyInstitutional Ownership
Cingulate Inc. stock logo
CING
Cingulate
41.31%
Estrella Immunopharma, Inc. stock logo
ESLA
Estrella Immunopharma
0.35%
Lifevantage Corporation stock logo
LFVN
Lifevantage
35.32%
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
32.40%

Insider Ownership

CompanyInsider Ownership
Cingulate Inc. stock logo
CING
Cingulate
4.33%
Estrella Immunopharma, Inc. stock logo
ESLA
Estrella Immunopharma
55.10%
Lifevantage Corporation stock logo
LFVN
Lifevantage
21.95%
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
20.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cingulate Inc. stock logo
CING
Cingulate
2012.25 million11.72 millionNot Optionable
Estrella Immunopharma, Inc. stock logo
ESLA
Estrella Immunopharma
N/A42.67 million19.16 millionNot Optionable
Lifevantage Corporation stock logo
LFVN
Lifevantage
26012.81 million9.99 millionOptionable
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
2906.18 million4.89 millionNot Optionable

Recent News About These Companies

Natural Alternatives Resolves Credit Agreement Issues

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cingulate stock logo

Cingulate NASDAQ:CING

$5.16 -0.07 (-1.26%)
As of 11:06 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas.

Estrella Immunopharma stock logo

Estrella Immunopharma NASDAQ:ESLA

$1.26 -0.01 (-0.79%)
As of 11:06 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.

Lifevantage stock logo

Lifevantage NASDAQ:LFVN

$4.79 -0.23 (-4.50%)
As of 11:06 AM Eastern
This is a fair market value price provided by Massive. Learn more.

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.

Natural Alternatives International stock logo

Natural Alternatives International NASDAQ:NAII

$2.74 +0.01 (+0.18%)
As of 10:57 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. The company was founded in 1980 and is headquartered in Carlsbad, California.